NATIONAL HEALTH INVESTORS, INC. - FORM 8-K
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2007 (February 2, 2007)
NATIONAL HEALTH INVESTORS, INC.
(Exact name of registrant as specified in its charter)
         
Maryland   001-10822   62-1470956
         
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)
100 Vine Street, Suite 1202
Murfreesboro, TN 37130
(Address of principal executive offices)
(615) 850-9100
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year,
if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 8.01. Other Events
Item 9.01. Financial Statements and Exhibits
SIGNATURE
EX-99 PRESS RELEASE 02/02/07


Table of Contents

Item 8.01. Other Events.
     On February 2, 2007, National Health Investors, Inc. (the “Company”) issued a press release regarding its response to the offer received from AdamsMark. The press release is attached hereto as Exhibit 99, which is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)   Exhibits
     
Number   Exhibit
 
   
99
  Press Release dated February 2, 2007.
SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
             
    NATIONAL HEALTH INVESTORS, INC.    
 
 
  By:   /s/ Richard F. LaRoche, Jr.    
 
           
 
  Name:   Richard F. LaRoche, Jr.    
 
  Title:   Chairman of Special Committee    
Date: February 2, 2007